SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Comparison Between Screening and Confirmatory Serological Assays in Blood Donors in a Region of South Italy
8 references·0 citing·31 second hop
Comparison Between Screening and Confirmatory Serological Assays in Blood Donors in a Region of South Italy (2014)Comparison Between Screening and Confirma…Expert Consensus Statement on achieving self‐sufficiency in safe blood and blood products, based on voluntary non‐remunerated blood donation (VNRBD)* (2012)Expert Consensus Statement on…International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)International survey on NAT t…The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing (2010)The significance of repeat te…Nucleic acid testing (NAT) in high prevalence–low resource settings (2010)Nucleic acid testing (NAT) in…Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Infectivity of human immunode…Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)Impact of nucleic acid testin…Analysis of voluntary blood donors with biologic false reactivity on chemiluminescent immunoassays and implications for donor management (2003)Analysis of voluntary blood d…An estimate of the current risk of transmitting blood‐borne infections through blood transfusion in Italy (2002)An estimate of the current ri…Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Comparative analysis of triplex nucleic acid test assays in United States blood donors (2013)Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? (2013)History and Future of Nucleic Acid Amplification Technology Blood Donor Testing (2019)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)The Risk of Transfusion-Transmitted Viral Infections (1996)Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Health and economic impact of posttransfusion hepatitis B and cost‐effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union (2003)Positivity of HIV, hepatitis B and hepatitis C in patients enrolled in a confidential self-exclusion system of blood donation: a cross-sectional analytical study (2010)The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre. (2014)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)Loss of volunteer blood donors because of unconfirmed enzyme immunoassay screening results. Retrovirus Epidemiology Donor Study (1997)False-Positive HIV-1 Test Results in a Low-Risk Screening Setting of Voluntary Blood Donation (1998)Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays (2003)Can We Improve the Management of Blood Donors With Nonspecific Reactivity in Viral Screening and Confirmatory Assays? (2005)Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: Evaluation of two chemiluminescent immunoassay systems (2014)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions (2009)Prevalence and prevalence trends of transfusion transmissible infections among blood donors at four chinese regional blood centers between 2000 and 2010 (2012)Nucleic acid amplification testing in Indian blood banks: A review with perspectives (2017)Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource‐poor settings (2005)Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa (2009)Trends in prevalence, incidence, and residual risk of major transfusion‐transmissible viral infections in United Arab Emirates blood donors: impact of individual‐donation nucleic acid testing, 2004 through 2009 (2012)Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia (2017)Towards 100% voluntary blood donation: a global framework for action. (2010)Why Do Blood Donors Lapse or Reduce Their Donation's Frequency? (2015)A systematic review of incentives in blood donation (2017)Challenges for Plasma-Derived Medicinal Products (2023)
this work references cited by second hop

References

  • 2009Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion221 cited
  • 2011International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009191 cited
  • 2012Expert Consensus Statement on achieving self‐sufficiency in safe blood and blood products, based on voluntary non‐remunerated blood donation (VNRBD)*125 cited
  • 2008Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey99 cited
  • 2002An estimate of the current risk of transmitting blood‐borne infections through blood transfusion in Italy56 cited
  • 2010Nucleic acid testing (NAT) in high prevalence–low resource settings47 cited
  • 2003Analysis of voluntary blood donors with biologic false reactivity on chemiluminescent immunoassays and implications for donor management30 cited
  • 2010The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing23 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work